0001209191-16-151999.txt : 20161123
0001209191-16-151999.hdr.sgml : 20161123
20161123183347
ACCESSION NUMBER: 0001209191-16-151999
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161122
FILED AS OF DATE: 20161123
DATE AS OF CHANGE: 20161123
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ChemoCentryx, Inc.
CENTRAL INDEX KEY: 0001340652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943254365
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-210-2900
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bekker Petrus
CENTRAL INDEX KEY: 0001422997
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35420
FILM NUMBER: 162017526
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-11-22
0
0001340652
ChemoCentryx, Inc.
CCXI
0001422997
Bekker Petrus
C/O CHEMOCENTRYX, INC.
850 MAUDE AVENUE
MOUNTAIN VIEW
CA
94043
0
1
0
0
Chief Medical Officer
Common Stock
2016-11-22
4
M
0
1250
6.30
A
54844
D
Common Stock
2016-11-22
4
S
0
1250
8.30
D
53594
D
Stock Option (right to buy)
6.30
2016-11-22
4
M
0
1250
D
2010-08-10
2020-08-10
Common Stock
1250
47760
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
As of November 22, 2016 and prior to this transaction, the option fully vested
Not applicable.
/s/ Susan M. Kanaya, as Attorney-in-Fact
2016-11-23